These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7886321)

  • 1. Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients.
    Ziegler TR; Leader I
    Semin Respir Infect; 1994 Dec; 9(4):240-7. PubMed ID: 7886321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone administration during nutritional support: what is to be gained?
    Ziegler TR
    New Horiz; 1994 May; 2(2):244-56. PubMed ID: 7922450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone in HIV/AIDS: current uses and future prospects.
    Laurence J
    Pediatr AIDS HIV Infect; 1995 Oct; 6(5):281-91. PubMed ID: 11361393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and splanchnic metabolic response to exogenous human growth hormone.
    Dahn MS; Lange MP
    Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with GH and IGF-1 in critical illness.
    Teng Chung T; Hinds CJ
    Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient.
    Voerman HJ; Strack van Schijndel RJ; de Boer H; van der Veen EA; Thijs LG
    Neth J Med; 1992 Dec; 41(5-6):229-44. PubMed ID: 1494402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with growth hormone and insulin-like growth factor-I in critical illness.
    Carroll PV
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):435-51. PubMed ID: 11800516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and cellular immune functions in septic mice treated with growth hormone (GH) and insulin-like growth factor-I (IGF-I).
    Schmitz D; Kobbe P; Lendemanns S; Wilsenack K; Exton M; Schedlowski M; Oberbeck R
    Growth Horm IGF Res; 2008 Jun; 18(3):245-52. PubMed ID: 18023601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human recombinant growth hormone on donor-site healing in burned adults.
    Losada F; García-Luna PP; Gómez-Cía T; Garrido M; Pereira JL; Marín F; Astorga R
    World J Surg; 2002 Jan; 26(1):2-8. PubMed ID: 11898025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinology in intensive care medicine: new insights and therapeutic consequences.
    Van den Berghe G
    Verh K Acad Geneeskd Belg; 2002; 64(3):167-87; discussion 187-8. PubMed ID: 12238241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and fish immune system.
    Yada T
    Gen Comp Endocrinol; 2007; 152(2-3):353-8. PubMed ID: 17382328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for growth hormone therapy in refractory critical illness?
    Taylor BE; Buchman TG
    Curr Opin Crit Care; 2008 Aug; 14(4):438-44. PubMed ID: 18614909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human growth hormone in patients with acute renal failure.
    Saadeh E; Ikizler TA; Shyr Y; Hakim RM; Himmelfarb J
    J Ren Nutr; 2001 Oct; 11(4):212-9. PubMed ID: 11680002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial.
    Sevette A; Smith RC; Aslani A; Kee AJ; Hansen R; Barratt SM; Baxter RC
    Clin Nutr; 2005 Dec; 24(6):943-55. PubMed ID: 16083996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness.
    Cooney RN; Shumate M
    Vitam Horm; 2006; 74():317-40. PubMed ID: 17027521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of gammahydroxybutyrate on hypermetabolism and wound healing in a rat model of large thermal injury.
    Murphy KD; Rose MW; Chinkes DL; Meyer WJ; Herndon DN; Hawkins HK; Sanford AP
    J Trauma; 2007 Nov; 63(5):1099-107. PubMed ID: 17993957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severely burned patients after surgery: recombinant human growth hormone therapy its metabolic effects].
    Chai J; Hao D; Wu Y; Shen C; Guo Z; Sheng Z
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):107-11. PubMed ID: 11955392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.